Inventor · disambiguated record
Jean-Paul Castaigne
Also filed as: CASTAIGNE JEAN-PAUL
8 granted patents·16 pending applications·65 citations·filing 1984–2017
84Inventor score
Top patents by PatentIndex Score
24 records- 0192US8039432B2Method of treatment of diabetes and/or obesity with reduced nausea side effectCONJUCHEM LLC·Filed 2006·Granted Oct 18, 2011·38 cites·28 claims
- 0279US9173891B2Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analogCASTAIGNE JEAN-PAUL·Filed 2010·Granted Nov 3, 2015·6 cites·16 claims
- 0378US8921314B2Conjugates of GLP-1 agonists and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Granted Dec 30, 2014·5 cites·8 claims
- 0477US9161988B2Multimeric peptide conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2010·Granted Oct 20, 2015·6 cites·14 claims
- 0577US8710013B2Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and useDEMEULE MICHEL·Filed 2009·Granted Apr 29, 2014·5 cites·31 claims
- 0668US10980892B2Methods for the treatment of leptomeningeal carcinomatosisANGIOCHEM INC·Filed 2016·Granted Apr 20, 2021·1 cites·19 claims
- 0758US2016106856A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 0857US9914754B2Conjugates of neurotensin or neurotensin analogs and uses thereofCASTAIGNE JEAN PAUL·Filed 2009·Granted Mar 13, 2018·0 cites·25 claims
- 0957US2011288011A1Peptide therapeutic conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Application pending·0 cites
- 1052US2017281787A1Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxinANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 1149US4642306ACyclic dithiodiacetamides and compositions containing themSANOFI SA·Filed 1984·Granted Feb 10, 1987·4 cites·7 claims
- 1246US2011288009A1Leptin and leptin analog conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2009·Application pending·0 cites
- 1345US2018015180A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2017·Application pending·0 cites
- 1445US2006241019A1Long lasting insulin derivatives and methods thereofBRIDON DOMINIQUE P·Filed 2004·Application pending·0 cites
- 1542US2012277158A1Compositions and methods for the transport of therapeutic agentsCASTAIGNE JEAN-PAUL·Filed 2010·Application pending·0 cites
- 1641US2016263236A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 1741US2015290341A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 1839US2015174267A1Compositions and methods for the transport of therapeutic agentsANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 1937US2016263235A1Peptide therapeutic conjugates and uses thereofANGIOCHEM INC·Filed 2015·Application pending·0 cites
- 2036US2013280281A1Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereofCASTAIGNE JEAN-PAUL·Filed 2011·Application pending·0 cites
- 2135US2014335163A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2012·Application pending·0 cites
- 2235US2015147310A1Targeted enzyme compounds and uses thereofANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 2335US2015037311A1Targeted lysosomal enzyme compoundsANGIOCHEM INC·Filed 2012·Application pending·0 cites
- 2426US2012196803A1Fusion proteins for delivery of gdnf and bdnf to the central nervous systemDEMEULE MICHEL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Paul Castaigne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →